CJC-1295 + Ipamorelin is a combined research peptide blend studied in laboratory settings for its synergistic effects on growth hormone secretion pathways. CJC-1295 is a GHRH analogue that stimulates growth hormone release while Ipamorelin is a selective growth hormone secretagogue. Together this combination is widely researched for its potential effects on hormonal signaling, metabolic regulation and recovery-related biological processes. Each vial contains 10MG of lyophilized CJC-1295 + Ipamorelin blend with purity ≥ 99%, verified by third-party HPLC testing. Intended strictly for research and laboratory use only. Not for human consumption